Gaudioso Ángel, Silva Teresa P, Ledesma María Dolores
Centro Biología Molecular Severo Ochoa (CSIC-UAM), Madrid, Spain.
Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Portugal.
Adv Drug Deliv Rev. 2022 Nov;190:114532. doi: 10.1016/j.addr.2022.114532. Epub 2022 Sep 16.
The lack of available treatments and fatal outcome in most lysosomal storage disorders (LSDs) have spurred research on pathological mechanisms and novel therapies in recent years. In this effort, experimental methodology in cellular and animal models have been developed, with aims to address major challenges in many LSDs such as patient-to-patient variability and brain condition. These techniques and models have advanced knowledge not only of LSDs but also for other lysosomal disorders and have provided fundamental insights into the biological roles of lysosomes. They can also serve to assess the efficacy of classical therapies and modern drug delivery systems. Here, we summarize the techniques and models used in LSD research, which include both established and recently developed in vitro methods, with general utility or specifically addressing lysosomal features. We also review animal models of LSDs together with cutting-edge technology that may reduce the need for animals in the study of these devastating diseases.
近年来,大多数溶酶体贮积症(LSDs)缺乏有效的治疗方法且预后不良,这推动了对其病理机制和新型疗法的研究。在此过程中,细胞和动物模型的实验方法得以发展,旨在应对许多LSDs中的主要挑战,如患者个体差异和脑部状况。这些技术和模型不仅增进了我们对LSDs的了解,也为其他溶酶体疾病提供了新认识,还为溶酶体的生物学作用提供了基本见解。它们还可用于评估传统疗法和现代药物递送系统的疗效。在此,我们总结了LSD研究中使用的技术和模型,包括已确立的和最近开发的体外方法,这些方法具有普遍适用性或专门针对溶酶体特征。我们还综述了LSD的动物模型以及前沿技术,这些技术可能会减少在研究这些毁灭性疾病时对动物的需求。